The obesity pandemic has been a burden globally for decades. The current COVID-19 pandemic has superimposed its morbidity, especially on those with the disease of obesity and obesity-related comorbidities such as type 2 diabetes.
The COVID and Obesity (COVesity) pandemic will have a considerable impact for some time, and the behavioural change around controlling the spread of COVID-19 is already leading to a reduction in activity, poorer food choices and a new spike in obesity. These 2 pandemics must be contained together.
To understand this unique relationship, PanSurg has created obesity-related workstreams, resources and research on this important subject. The COMS-UK and CONSULT-19 studies will allow data collection on service-provision and training in obesity services and our webinar has already highlighted the important areas of concern.
Once bariatric surgery recommences in the UK and other places, it will be important to collect data on outcomes and morbidities related to COIVD-19 and to share best new practices in order to make surgery as safe as possible.